Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

Research Group(s)

  • Prostate and Urologic Cancer

Sponsor

University of Alabama at Birmingham

Status

Recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT04091022

This is a single institution, randomized, placebo-controlled, double-blind phase IIB trial of
1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non
melanoma skin cancer/ keratinocytic cancers.

Intervention

Solaraze and Vaniqa

Condition

Non-melanoma Skin Cancer

Investigators

Craug Elmets, MD, Craig Elmets, MD

See list of participating sites